GLP-1 and GIP Therapies in Lipodystrophy: Expert Insights with Dr.Oral & Dr. Foss-Freitas
Автор: Lipodystrophy United
Загружено: 2025-06-05
Просмотров: 156
In this special Lunch & Learn hosted by Lipodystrophy United, Dr. Elif Oral and Dr. Maria Cristina Foss-Freitas discuss the latest research and clinical experience using GLP-1 and dual GIP/GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) in treating lipodystrophy.
You’ll hear:
Real-world data from patients with FPLD, APL, and CGL
Insights into the metabolic impact of these therapies
Case studies, outcomes on triglycerides, insulin, and liver fat
Discussion on food noise, appetite regulation, GI side effects, and future clinical trials
Live Q&A with patients and caregivers
Whether you're a patient, caregiver, or clinician, this session offers valuable knowledge about emerging treatment strategies for managing hunger, body fat distribution, and metabolic symptoms in lipodystrophy.
🔗 Learn more at: www.lipodystrophyunited.org
📩 Questions? Email us at [email protected]
#Lipodystrophy #GLP1 #GIP #Ozempic #Mounjaro #Tirzepatide #RareDisease #PatientEducation
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
